Financial reports
10-K
2023 FY
Annual report
26 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q1
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
10-K
2021 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
8 Nov 21
Current reports
8-K
Krystal Biotech Announces Fourth Quarter and Full Year 2023
26 Feb 24
8-K
Krystal Biotech Announces Third Quarter 2023 Financial Results and Provides Business Update
6 Nov 23
8-K
Departure of Directors or Certain Officers
7 Aug 23
8-K
Krystal Biotech Announces Second Quarter 2023 Financial Results and
7 Aug 23
8-K
Krystal Biotech Announces Pipeline Expansion into Oncology
26 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
23 May 23
8-K
Krystal Biotech Announces $160 Million Private Placement Equity Financing
22 May 23
8-K
Regulation FD Disclosure
19 May 23
8-K
Regulation FD Disclosure
11 May 23
8-K
Entry into a Material Definitive Agreement
8 May 23
Registration and prospectus
S-8
Registration of securities for employees
26 Feb 24
S-3ASR
Automatic shelf registration
18 Jul 23
424B5
Prospectus supplement for primary offering
8 May 23
S-3ASR
Automatic shelf registration
6 Apr 23
S-8
Registration of securities for employees
2 Feb 23
S-8
Registration of securities for employees
17 Feb 22
424B2
Prospectus for primary offering
1 Dec 21
424B5
Prospectus supplement for primary offering
29 Nov 21
424B2
Prospectus for primary offering
4 Feb 21
424B5
Prospectus supplement for primary offering
2 Feb 21
Proxies
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 23
DEF 14A
Definitive proxy
4 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
6 Apr 21
DEF 14A
Definitive proxy
6 Apr 21
DEFA14A
Additional proxy soliciting materials
8 May 20
DEF 14A
Definitive proxy
13 Apr 20
Other
UPLOAD
Letter from SEC
24 Apr 23
CORRESP
Correspondence with SEC
11 Apr 23
UPLOAD
Letter from SEC
30 Mar 23
EFFECT
Notice of effectiveness
15 Oct 18
UPLOAD
Letter from SEC
10 Oct 18
CORRESP
Correspondence with SEC
9 Oct 18
EFFECT
Notice of effectiveness
19 Sep 17
CORRESP
Correspondence with SEC
15 Sep 17
CORRESP
Correspondence with SEC
15 Sep 17
CORRESP
Correspondence with SEC
7 Sep 17
Ownership
4
Suma Krishnan
11 Mar 24
4
Krish S Krishnan
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
4
KATHRYN ROMANO
1 Mar 24
4
KATHRYN ROMANO
1 Mar 24
4
Suma Krishnan
1 Mar 24
4
Krish S Krishnan
1 Mar 24
4
Suma Krishnan
28 Feb 24
4
Krish S Krishnan
28 Feb 24